L3Harris Technologies (LHX) arrived at Thursday’s session trading around $302, having absorbed a 15% drawdown over the past month despite reporting one of the most operationally impressive quarters in the company’s recent history. The disconnect between what the business delivered in Q1 and where the stock is sitting tells you everything about the current defence sector mood — strong fundamentals, suppressed sentiment.
Start with the numbers. Q1 2026 revenue came in at $5.744 billion, beating the $5.4 billion Wall Street consensus by a meaningful margin. EPS of $2.72 cleared the $2.58 estimate. Management raised full-year EPS guidance to $11.40 to $11.60, up from $11.30 to $11.50. Organic revenue grew 15% — a figure that is exceptional by any measure in the defence contracting sector.
The book-to-bill ratio for the quarter was 1.4 times, meaning LHX booked $7.8 billion in orders against $5.7 billion in revenue. International book-to-bill hit 2.2 times, reflecting accelerating demand from NATO allies and Indo-Pacific partners. Backlog has nearly doubled to a record $40.7 billion, and CEO Christopher Kubasik said on the earnings call that if Munitions Acceleration Council programme negotiations conclude as expected, the company’s backlog could reach $60 to $70 billion in the next twelve months.
The Missile Solutions division is where the structural story gets most interesting. LHX created its Missile Solutions (MSL) segment in early 2026 by bringing together missile capabilities from across the company, including the legacy Aerojet Rocketdyne operations acquired in 2023. In April, the company closed a $1 billion strategic investment from the Department of War in the MSL business, structured as a convertible preferred security that will convert into equity at IPO.
The government also received warrants to purchase additional MSL common stock. The funds are earmarked for expanding and modernising solid rocket motor production facilities in Camden, Arkansas; Huntsville, Alabama; and Orange, Virginia — facilities critical to manufacturing PAC-3, THAAD, Tomahawk, and Standard Missile systems that are being consumed at historic rates. The new missile entity has been named Axyv following a confidential S-1 filing, with the IPO targeting the second half of 2026 pending market conditions. L3Harris will retain more than 80% ownership post-IPO and will continue consolidating MSL’s financial results. An additional $1.27 billion facility investment in Virginia was announced alongside the state’s governor, adding further production scale.
The company also agreed to sell 60% of its space propulsion and power systems business as part of broader portfolio shaping to sharpen strategic focus. Goldman Sachs maintained its Buy rating on LHX this week, Argus Research reaffirmed Buy, and Bernstein trimmed its target to $405 from $435 — still implying more than 30% upside from Thursday’s close. Cathie Wood’s ARK Innovation funds added LHX to their holdings this week, providing a speculative tailwind alongside the institutional conviction already evident in the consensus.
At a P/E that sits slightly below the aerospace and defence industry average, and with a 1-year total shareholder return of over 43% even after the recent pullback, LHX screens as attractively valued relative to its growth trajectory. The backlog provides genuine multi-year revenue visibility. The Axyv IPO has the potential to crystallise value that the market is not currently recognising in LHX’s consolidated share price. The company’s articulation of its strategic priorities — space sensing and missile defence, ISR aircraft missionisation, resilient communications, and missiles and munitions — aligns precisely with where defence spending is accelerating. At $302, LHX looks like a stock that the market will eventually need to reprice higher, assuming defence sentiment recovers from its current geopolitically uncertain state.
